Overview
Each health care-related litigation case is unique and demands a customized approach. Whether the situation calls for aggressive motions practice, mediation, arbitration, or trial by jury, our seasoned attorneys are well-equipped to strategize and execute the most effective legal solutions for our clients. We are committed to helping health care organizations avoid unnecessary litigation, minimize risks when litigation is inevitable, and preserve valuable relationships.
Our litigation experience for health care organizations includes (but is not limited to):
Commercial Business and Individual Disputes: Breach of contract, enforcement of contracts, payor/provider reimbursement disputes, non-competes, wrongful terminations, discrimination, harassment, retaliation, trademark or copyright infringement and other actions taken against or by health care organizations benefit from our experience and industry knowledge.
Administrative Hearings and Appeals: We have extensive experience with the administrative hearings and appeals process in Kentucky, Ohio, and Tennessee and have appeared before most state boards and agencies. We also have significant experience with federal administrative hearings and appeals before the Medicare Office of Hearings and Appeals, the Departmental Appeals Board, and the Provider Reimbursement Review Board.
Amicus Curiae Representation: With our in-depth knowledge and experience, we are often sought after to file amicus curiae briefs on behalf of healthcare providers, trade organizations or other stakeholders. Our commitment to the healthcare community extends beyond individual cases, as we actively contribute to shaping legal precedents.
False Claims Act Defense: We represent clients across the country in various Medicare and Medicaid fraud and abuse cases in matters brought by the U.S. Department of Justice, state agencies and/or private whistleblowers. at the state and federal level in various Medicare and Medicaid fraud and abuse cases. In addition, our False Claims Act team works with health care organizations to conduct compliance audits and internal investigations designed to reduce the likelihood of a violation.
Class Actions: Our team has experience managing the propriety of class action formation and the defense of class action litigation.
Intellectual Property Litigation: Our litigation team represents health care organizations in intellectual property disputes involving trademarks, copyrights, patents, and unfair competition. We regularly defend and enforce IP rights for hospitals, health systems, physician groups, digital health providers, and related organizations where brand identity, proprietary technology, and confidential information are critical business assets.
Our experience includes litigating trademark infringement and unfair competition claims in federal and state courts, pursuing and defending appellate matters, and navigating proceedings before the Trademark Trial and Appeal Board. We also work proactively with health care clients to resolve intellectual property disputes efficiently through strategic motion practice, summary judgment, and administrative proceedings—often avoiding prolonged litigation while protecting core business interests.
Product Liability: Our litigation team represents health care manufacturers, suppliers, distributors, and providers in product liability matters involving medical devices, pharmaceuticals, equipment, and other health care‑related products. We understand that product liability claims can pose significant legal, financial, and reputational risks—threatening patient safety, regulatory compliance, supply chains, and market viability.
Our experience includes defending claims involving alleged design defects, manufacturing issues, failure‑to‑warn allegations, and complex scientific and engineering questions. We also counsel health care clients on product recalls, warning and labeling issues, and responses to inquiries from governmental agencies, helping organizations manage risk while maintaining continuity of care. In addition to litigation, we work proactively with clients through audits and risk‑assessment initiatives focused on safety, training, marketing, and warranty practices to reduce exposure before disputes arise.
Receiverships and Creditors’ Right Actions: When business relationships go bad for any reason and rights need to be asserted or protected, we have litigators who can protect the assets, the business and/or the parties, including receiverships, obtaining and enforcing judgments, bankruptcy proceedings, and other actions.
Medical Negligence & Wrongful Death: Our health care litigators handle cases involving medical negligence, wrongful death, and birth trauma claims. We bring a wealth of experience representing hospitals, nurses, physicians, and other health care providers in mediations, the Supreme Court of Ohio, appellate courts, and jury trials.
White Collar Defense & Investigations: Our seasoned litigators represent health care organizations and their leaders in government investigations and enforcement‑related litigation. We regularly advise hospitals, health systems, physician groups, long‑term care providers, and ancillary service providers in matters involving criminal, civil, and administrative exposure. Our team includes former prosecutors who are experienced at both avoiding criminal and collateral consequences, and at defending providers who find themselves in the midst of criminal prosecutions.
Our experience includes internal investigations, grand jury matters, and parallel criminal, civil, and regulatory proceedings arising from allegations of health care fraud, false claims, reimbursement and billing issues, Stark Law and Anti‑Kickback Statute compliance, FDA matters, DEA matters, antitrust investigations, and data privacy and HIPAA enforcement actions. We also counsel clients on voluntary disclosures, compliance remediation, and risk mitigation strategies.
Experience
Professionals
- office 513.629.2805
- office 513.870.6682
- office 502.562.7342
- office 614.227.2319
- office 502.562.7588
- office 502.562.7111
- office 513.629.2724
- office 614.227.2307
- office 216.523.5468
- office 859.288.7469
- office 502.562.7246
- office 502.562.7526
- office 513.629.2792
- office 859.288.7415
- office 502.562.7367
- office 502.562.7169
- office 502.562.7278
- office 502.562.7560
- office 502.562.7305
- office 614.227.4857
- office 513.629.2799
- office 502.562.7334
- office 614.227.2394
- office 614.227.8870
- office 859.288.7631
- office 502.562.7365
- office 513.629.2812
- office 513.629.2747
- office 502.562.7330
- office 502.562.7212
Insights
News
Publications
Blog Posts
- Why the MultiPlan Case Matters to All ProvidersBlog Post
- Indiana’s New Non-Compete Regulation: Physician Non-Compete Agreements Prohibited Starting July 1, 2025Blog Post
- The Health Plan Fiduciary Maze: New Lawsuit Highlights Need to Navigate Carefully in the Era of TransparencyBlog Post
- Nationwide COVID-19 Public Health Emergency to End in MayBlog Post
- Public Health Emergency ExtendedBlog Post
- DOJ Brings Charges Against Defendants Alleging COVID-19 Related Fraud SchemesBlog Post
- FDA Authorizes COVID-19 Breathalyzer TestBlog Post
- Public Health Emergency ExtendedBlog Post
- Medicare Beneficiaries Eligible for Free Over-the-Counter COVID-19 TestsBlog Post
- CMS to Phase Out Blanket COVID-19 Waivers in Certain Healthcare FacilitiesBlog Post
- HHS to Reopen COVID-19 PRF ReportingBlog Post
- HHS Clawing Back Funds from Providers Who Did Not Comply with PRF TermsBlog Post
- Free COVID-19 Testing Options for Uninsured DwindlingBlog Post
- Second Booster Approved for Select Groups of the PopulationBlog Post
- OSHA Rulemaking on Permanent Healthcare COVID-19 StandardBlog Post
- Kentucky Legislature Votes to End the COVID-19 State of EmergencyBlog Post
- HHS Distributes $413 Million in Provider Relief FundsBlog Post
- Biden Administration Launches the Test to Treat InitiativeBlog Post
- Telehealth Waivers to be Extended 151 Days Beyond End of PHEBlog Post
- DOJ Appoints COVID-19 Fraud Enforcement Task Force DirectorBlog Post
- President Biden Extends National Emergency DeclarationBlog Post
- HHS Office of Inspector General to Pursue COVID Aid FraudBlog Post
- HHS Distributing Another $560 Million in Provider Relief Fund PaymentsBlog Post
- HHS Awards $55 Million to Increase Virtual CareBlog Post
- Provider Relief Fund Reportedly Running OutBlog Post
- CMS to Cover Free COVID-19 Tests for Medicare BeneficiariesBlog Post
- HHS To Audit HospitalsBlog Post
- HHS Distributes $2 Billion in Provider Relief FundsBlog Post
- HHS Awards $103 Million in Funds to Improve Healthcare Worker WellnessBlog Post
- New Kentucky State Health Plan Provisions for Hospital Spin-offs and Non-Emergency TransportBlog Post
- Public Health Emergency ExtendedBlog Post
- Coverage Mandated for Rapid At-Home COVID-19 TestsBlog Post
- AHA Urges Extension of the Public Health EmergencyBlog Post
- The Supreme Court Lifts Stay on Healthcare Vaccination MandateBlog Post
- CMS Announces Billing Change for COVID-19 Vaccine & Monoclonal Antibody Products for MA Plan BeneficiariesBlog Post
- Supreme Court to Hear Challenges to Vaccine MandatesBlog Post
- Vaccine Mandate Back in Place for Half of U.S.Blog Post
- Governor Beshear Declares a State of Emergency Regarding Nursing ShortageBlog Post
- CMS Suspends Enforcement of Vaccine Mandate for Health Care StaffBlog Post
- FDA & CDC Expands COVID-19 Booster EligibilityBlog Post
- HHS Announces Funds for Telehealth in Title X Family Planning ProgramBlog Post
- Court Halts Vaccine Mandate for Federal Contractors in KY, OH and TNBlog Post
- Courts Halt Vaccine Mandate for Health Care Workers NationwideBlog Post
- Governor Beshear Expands Booster Shot Eligibility in KentuckyBlog Post
- CMS Lifts Nursing Home Visitation RestrictionsBlog Post
- CMS to Assist State Survey Agencies in Backlog of Nursing Home Complaint and Recertification SurveysBlog Post
- States Challenge CMS Vaccine Mandate for Healthcare WorkersBlog Post
- FCC Awards Additional $42 Million to Telehealth ProvidersBlog Post
- CMS Issues COVID-19 Health Care Staff Vaccination Interim Final RuleBlog Post
- CDC Approves Pediatric COVID-19 Vaccine – Coverage Available Without Cost-SharingBlog Post
- Doctors’ Medicare Pandemic Pay Bump to Expire in 2022Blog Post
- OSHA Issues Emergency Temporary Standard Requiring Vaccinations or COVID-19 TestingBlog Post
- CMS Issues Guidance on Required COVID-19 CoverageBlog Post
- Provider Relief Fund Reporting to Continue After the Public Health EmergencyBlog Post
- FDA & CDC Approve Moderna and J&J BoostersBlog Post
- UnitedHealth Group to Repay Providers for COVID-19 Vaccine AdministrationBlog Post
- New Low Interest Loan Program to Support Rural Hospitals in KentuckyBlog Post
- Providers Settle Cases Over Provider Relief FundBlog Post
- HHS Launches Spanish Language AppBlog Post
- OCR Issues Guidance on HIPAA, COVID-19 Vaccination and the WorkplaceBlog Post
- Judge Rules Kentucky Hospital Employees are Subject to COVID-19 Vaccine MandateBlog Post
- Expanded Billing Discretion When Vaccinating SNF ResidentsBlog Post
- FCC Approves $41 Million in Funding for Telehealth ServicesBlog Post
- Non-Rural Providers Can Qualify for American Rescue Plan’s Rural FundBlog Post
- Pfizer Booster Shot Cleared by FDA and CDC for Those Over 65, Among OthersBlog Post
- Governor Beshear Expands Kentucky National Guard Support to More HospitalsBlog Post
- Governor Beshear Warns of Monoclonal Antibody ShortagesBlog Post
- CMS Launches Tool To Compare Nursing Home Vaccination RatesBlog Post
- DOJ Announces Criminal Charges in Alleged Health-Care Fraud Involving TelemedicineBlog Post
- $25.5 Billion in Funding Available For Health Care ProvidersBlog Post
- 60-day Grace Period Added On To First Provider Relief Fund Reporting DeadlineBlog Post
- Monoclonal Antibody Treatment Distribution ChangeBlog Post
- Federal Audits of Telehealth Are ComingBlog Post
- 100 Million Employees to Face Vaccine MandatesBlog Post
- Expanded Vaccination Requirements for Health Care SettingsBlog Post
- Kentucky Legislature Adopts House Joint Resolution 1 to Extend Emergency Executive OrdersBlog Post
- Advisories Issued by FDA, CDC, AMA and Others Against Use of Ivermectin to Treat COVID-19Blog Post
- CMS Expands Payments for At-Home VaccinationsBlog Post
- CMS Will Take Step Approach for Nursing Home Non-Compliance with Staff Vaccination RequirementsBlog Post
- CMS to Mandate COVID-19 Vaccines for Nursing Home StaffBlog Post
- CMS Provides Payment Reimbursement Guidance for Extra Doses of COVID-19 VaccineBlog Post
- Federal Government Expected to Continue Covering States’ Emergency COVID-19 CostsBlog Post
- CDC Updates Recommendations on COVID-19 Vaccinations for Pregnant IndividualsBlog Post
- OSHA Enforcing N95 Mask Requirements Applicable to Healthcare EmployersBlog Post
- FDA Approves Additional Vaccine Dose for Certain Immunocompromised IndividualsBlog Post
- HHS Requires Vaccination of its Healthcare WorkforceBlog Post
- Masks Required in Kentucky SchoolsBlog Post
- Kentucky Hospital Systems Require Vaccinations for Health Care WorkforceBlog Post
- Governor Beshear, Dr. Stack Provide Update on COVID-19 Delta Variant in Kentucky and Mask-Wearing GuidanceBlog Post
- HHS Announces $103 Million in Additional Grant Funding to Strengthen Resiliency and Address Burnout in the Health WorkforceBlog Post
- HHS Provides $398 Million to Small Rural Hospitals for COVID-19 Testing and MitigationBlog Post
- HHS Provides Nearly $144 Million to Support COVID-19 Response Efforts in Underserved CommunitiesBlog Post
- U.S. Surgeon General Issues Advisory During COVID-19 Vaccination Push Warning American Public About Threat of Health MisinformationBlog Post
- Professional Organizations Call for Mandatory COVID-19 Vaccinations Among Healthcare PersonnelBlog Post
- HHS Announces Rule to Protect Consumers from Surprise Medical BillsBlog Post
- HHS Allowing Providers More Time To Fulfill Reporting Requirements For COVID-19 AidBlog Post
- Judge Rules on Houston Methodist Hospital Workers' Vaccine Requirement ChallengeBlog Post
- Biden Administration to Invest $3 Billion from American Rescue Plan as Part of COVID-19 Antiviral Development StrategyBlog Post
- Gov. Beshear Lifts Face Covering MandateBlog Post
- CMS Issues Two New Reimbursement Codes in Response to FDA EUAs for Two COVID-19 Monoclonal Antibody TreatmentsBlog Post





























